These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 16887936)

  • 1. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PPARγ agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model.
    Grommes C; Karlo JC; Caprariello A; Blankenship D; Dechant A; Landreth GE
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):929-36. PubMed ID: 23358645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells.
    Grommes C; Landreth GE; Schlegel U; Heneka MT
    J Pharmacol Exp Ther; 2005 May; 313(2):806-13. PubMed ID: 15665144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
    Yamamoto Y; Ono T; Dhar DK; Yamanoi A; Tachibana M; Tanaka T; Nagasue N
    J Gastroenterol Hepatol; 2008 Jun; 23(6):930-7. PubMed ID: 18565023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts.
    Spagnolo A; Glick RP; Lin H; Cohen EP; Feinstein DL; Lichtor T
    J Neurosurg; 2007 Feb; 106(2):299-305. PubMed ID: 17410715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y; Ping J; Xu LM
    Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes.
    Spagnolo A; Grant EN; Glick R; Lichtor T; Feinstein DL
    Neurosci Lett; 2007 Apr; 417(1):72-7. PubMed ID: 17324516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
    Xiao Y; Yuan T; Yao W; Liao K
    FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.
    Lee KJ; Jang YH; Lee H; Yoo HS; Lee SR
    Eur J Neurosci; 2008 Jan; 27(2):334-42. PubMed ID: 18215232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
    Papi A; Tatenhorst L; Terwel D; Hermes M; Kummer MP; Orlandi M; Heneka MT
    J Neurochem; 2009 Jun; 109(6):1779-90. PubMed ID: 19457135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
    Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
    Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.
    Annicotte JS; Iankova I; Miard S; Fritz V; Sarruf D; Abella A; Berthe ML; Noël D; Pillon A; Iborra F; Dubus P; Maudelonde T; Culine S; Fajas L
    Mol Cell Biol; 2006 Oct; 26(20):7561-74. PubMed ID: 17015477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
    Shigeto T; Yokoyama Y; Xin B; Mizunuma H
    Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.
    Akahori T; Sho M; Hamada K; Suzaki Y; Kuzumoto Y; Nomi T; Nakamura S; Enomoto K; Kanehiro H; Nakajima Y
    J Hepatol; 2007 Dec; 47(6):784-92. PubMed ID: 17936399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
    Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
    Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
    Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.